Dr. Mohamad Ammar Ayass is a practicing physician specializing in pulmonary and critical care medicine. He received his medical doctor degree at the Damascus University College of Medicine, then completed his postdoctoral training at the University of Tennessee.
Dr. Ayass opened his own pulmonary clinic in west Texas and the DFW area, and funds the Ayass Lung Clinic, Ayass Laboratory, and Ayass Bioscience. Dr. Ayass believes in integrating molecular medicine into clinical practice in what he calls “engineering the medical practice”. He is interested in understanding the molecular aspect of diseases, such as thrombosis, coagulation, allergy, autoimmune diseases, cancer, and COVID-19. He opened the Genetic/Genomic, Epigenetic, and Omics program, and laboratory of flow cytometry, aptamer, and COVID-19 to help understand the role of pathophysiological diseases and allow the discovery of aptamers for diagnostics and therapeutics. Dr. Ayass plays a key role in research and development seeking to bridge science and precision patient care.
Short Biography
Dr. Mohamad Ammar Ayass is a practicing physician specializing in pulmonary and critical care medicine. He received his medical doctor degree at the Damascus University College of Medicine, then completed his postdoctoral training at the University of Tennessee.
Dr. Ayass opened his own pulmonary clinic in west Texas and the DFW area, and funds the Ayass Lung Clinic, Ayass Laboratory, and Ayass Bioscience. Dr. Ayass believes in integrating molecular medicine into clinical practice in what he calls “engineering the medical practice”. He is interested in understanding the molecular aspect of diseases, such as thrombosis, coagulation, allergy, autoimmune diseases, cancer, and COVID-19. He opened the Genetic/Genomic, Epigenetic, and Omics program, and laboratory of flow cytometry, aptamer, and COVID-19 to help understand the role of pathophysiological diseases and allow the discovery of aptamers for diagnostics and therapeutics. Dr. Ayass plays a key role in research and development seeking to bridge science and precision patient care.